Opioid agonist therapy (OAT) is a treatment in which prescribed opioid agonists are given to patients who live with Opioid use disorder (OUD). The benefits of this treatment include a more manageable withdrawal experience, cognitive improvement, and lower HIV transmission. The length of OAT varies from one individual to another based on their physiology, environmental surroundings, and quality of life.
The term medication for Opioid Use Disorder (MOUD) is used to describe medication including methadone and buprenorphine, which are used to treat patients with OUD.
Other terms that appear in the professional and popular literature include opioid replacement therapy, methadone maintenance, medication-assisted treatment (MAT) and medications for opioid use disorder (MOUD).
An opioid is considered a ligand, which is an ion or a molecule. An opioid ligand travels to the brain and attaches itself to an opioid receptor, which begins the effects of opioids. The mesolimbic system, which is the biological system that moderates the feeling of reward generated by dopamine, is the main system that is effected by opioids. Opioids stimulate the mesolimbic system to release a large amount of dopamine in the brain, which increases the effects of opioids: euphoria and numbness. The difference between an opioid and an opioid agonist is that opioids induce more intense effects and stay in the brain for a short amount of time. Conversely, an opioid agonist induces minimal effects and stays in the brain for a long time, which prevents the opioid user from feeling the effects of natural or synthetic opioids. However, the opioid receptors are still being used when an opioid agonist attaches, which prevents the effects of opioid withdrawal and can help prevent relapse. The two most common opioid agonists are methadone and buprenorphine.
The use of methadone for the treatment of opioid addiction dates back to the 1960s. Methadone treatments usually last for multiple years, although they can last for decades.
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.
thumb|Tabac blond séché et haché, la substance psychotrope la plus consommée dans le monde. vignette|droite|Un assortiment de différents psychotropes vignette|L'alcool est un des psychotropes les plus largement disponibles et consommés. Un psychotrope est un produit ou une substance chimique qui agit principalement sur l'état du système nerveux central en y modifiant certains processus biochimiques et physiologiques cérébraux, sans préjuger de sa capacité à induire des phénomènes de dépendance, ni de son éventuelle toxicité.
Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation, and a low mood. Addiction and dependence are important components of opioid use disorder.
Un opioïde est une substance psychotrope de synthèse (fentanyl) ou naturelle (opiacés qui agissent sur les récepteurs aux peptides opioïdes) dont les effets sont similaires à ceux de l'opium sans y être chimiquement apparentés. Les opioïdes exercent leurs effets par stimulation directe ou indirecte des récepteurs opiacés, qui sont surtout logés dans les systèmes nerveux central et parasympathique. Les récepteurs de ces organes servent de médiateurs à la fois aux effets bénéfiques et néfastes des opioïdes.
This course introduces the student to the fudamentals of pharmacology, pharmacokinetics and drug-receptor interactions. It discusses also pharmacogenetics and chronopharmacology, to exemplify the chal
Explore la pharmacologie de la douleur, y compris la transduction, les agents sensibilisants, les agonistes des récepteurs opioïdes, les AINS et les traitements neuropathiques de la douleur.
Explore la pharmacologie de la douleur, y compris la douleur nociceptive, les agents sensibilisants, les agonistes des récepteurs opioïdes, les AINS et les mécanismes médicamenteux.
Explore la maladie d'Alzheimer, l'anxiété, la douleur et le système rénine-angiotensine, y compris le développement du premier inhibiteur de la rénine pour le traitement clinique.
G protein-coupled receptors play essential roles in cellular processes such as neuronal signaling, vision, olfaction, tasting, and metabolism. As GPCRs are the most important drug targets, understanding their interactions with ligands is of utmost importan ...
AMER CHEMICAL SOC2020
After a failure of "One-Size-Fits-All" approach on traditional treatment of diseases, the age of multi-faceted personalized medicine came into being for tailoring therapy to get the best response in the highest safety margin. Personalized drug dosage is on ...
BackgroundSchwannomas of the VIIIth cranial nerve are benign tumours, with vast majority occurring in vestibular division. Rarely, they can also arise from distal branches of cochlear, superior or inferior vestibular. We review our experience with Gamma Kn ...